New Potent Sulfonamide-Based Inhibitors of S. aureus Biotin Protein Ligase

The key regulatory metabolic enzyme, biotin protein ligase (BPL), is an attractive target for the development of novel antibiotics against multi-drug-resistant bacteria, such as